Shire is evaluating how to secure financing for a Salix bid, one of the sources said. The sources cautioned that Shire may still decide against a bid given the deal’s complexity. Salix is considering its options in the midst of a management shakeup and inventory issues, sources previously told Reuters. Valeant Pharmaceuticals International Inc (VRX.TO) has also been exploring an offer for Salix, the people added.